52 wk high is 20.09. It tanked when a RS was announced. Has'nt come back to that level, let alone the $50 it was trading at a year and a half before that!!
BLA BLA BLAH BLAH!!! It is nice to see Isacc talking to himself ang getting into a frenzy. With all the BLAtherings the stock has barely budged in the last month! That 10 to 1 RS is like a heavy boulder sitting on top of this stock. What a sharp move by the management. The least they can do is to release some positively positive news that will get this one from under the rock.
The problem with some of these pumpers is that they are cutting the empty half of the glass with the DSMB cutter and calling the glass full! Well, personally I am getting tired of this stock slide, and I am still peeved at the way management made the stock a ten-bagger!!?? to award themselves hefty compensation.
Looks like a paid pumper. Has been pumping for a while but market does not listen to Isaac. Stock still at 1.75. NVAX meanwhile has gone up by 125%!! Well, let's see if what Grey has to say tomorrow will boost the price.
Market has been moving up and DVAX has been moving down despite all the rational or irrational speculative babble from Isaac. Stock has gone down from 18.75 to 16 in a month. So just cool it. Let's see if this stock will move up with some good news. The last time there was so much excitement this stock rallied to 5 and then tanked to 1 with bad news. This time, at 1.6, there is not much downside. Many thought this would be a ten bagger. But, the only ones getting the benefit are the management with the stock options.
There was a similar guy pumping this stock and blowing it high with numerous posts the last time around. Daum pricked the bubble and the stock dropped from 5 to less than 2. None of us have any information on the progress of the trial. So all these speculative posts are meaningless. Hold your breath, and wait for the news - hopefully positive, and that will move the stock.
There is no point jabbing each other in the dark on this topic. We will know for sure soon enough. FDA will need to weigh the benefits of preventing further Hep infections and the sizable associated health care costs against another round and another two years of tests (assuming no SAEs). Yes, they can continue to collect data post-licensure. Reason should prevail this time!
You are talking to yourself and getting excited! What is there to get excited about $1.79? I was looking for a runaway overshoot at $20 pre-split with some positive news announcement. But, with the 10:1 RS, that's just a dream! The only reason I can think for this massive RS is for DVAX to shop themselves for a TO. Nobody wants to buy a $1.79 stock company.